Introduction: Propolis has been used traditionally for different human diseases and even recently as dental biomaterials because of its antibacterial, antimycotic, and anti-inflammatory properties. However, a proper correlation between in vitro and in vivo anti-inflammatory properties has not been clearly established. Methods: The composition of propolis was determined by high-performance liquid chromatography–ultraviolet mass spectrometry (HPLC-UV-MS). Viability of ethanolic propolis solution was evaluated by thiazolyl blue tetrazolium bromide (MTT) assay on murine macrophages. The anti-inflammatory properties were assessed both in vitro through the enzyme-linked immunosorbent assay (ELISA) quantification of various cytokines and in vivo by induced edemas. Results: Chemical analysis showed pinocembrin, pinobanksin-3-O-acetate, and pinobanksin-3-O-propionate as the main components of propolis. Macrophage viability was high (106%) when propolis was used up to 50 µg/mL. ELISA studies showed a reduction in the expression of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) up to 145 pg/mL, 350 pg/mL, and 210 pg/mL, respectively, while the anti-inflammatory cytokines (IL-10 and IL-4) were increased up to 833 pg/mL and 446 pg/mL. Finally, edema was reduced on paw and ear mice by 9% and 22%, respectively. Conclusion: Mayan propolis has strong in vitro anti-inflammatory properties without compromising macrophage viability, resulting in a low-to-mild in vivo anti-inflammatory response.
The synthesis of the benzylisoquinoline alkaloids, sanguinarine and berberine, was monitored in Argemone mexicana L. (Papaveracea) throughout the early stages of its hypocotyl and seedling development. Sanguinarine was detected in the cotyledons right after hypocotyl emergence, and it increased continuously until the apical hook unbent, prior to the cotyledonary leaves unfolding, when it abruptly fell. In the cotyledonary leaves, it also remained at low levels. Throughout development, berberine accumulation required the formation of cotyledonary leaves, whereas it was quickly detected in the hypocotyl from the time it emerged. Interestingly, the alkaloids detected in the cotyledons could have been imported from hypocotyls, because no transcriptional activity was detected in there. However, after turning into cotyledonary leaves, important levels of gene expression were noted. Taken together, these results suggest that the patterns of alkaloid tissue distribution are established from very early development, and might require transport systems.
Plants of the Phoradendron genus have been traditionally used for their lipid- and glucose-lowering effects. However, the compounds responsible for these effects and the overall chemical profile of these plants have not been thoroughly investigated. We aimed to characterize the metabolome of leaves, stems, and aerial parts of the Phoradendron brachystachyum plant. We used mass spectrometry and colorimetric screening techniques (with various solvents) to identify and characterize the metabolites present. We also evaluated the antioxidant (FRAP, ORAC, TEAC, and DPPH assays) and inhibitory effects on pancreatic lipase and α-glucosidase enzymes of hydrophilic extracts. Furthermore, we compared the molecular fingerprints between the identified metabolites and FDA-approved drugs to gain insights into the metabolites that might be responsible for the observed effects on enzymes. Our findings revealed the presence of 59 putative metabolites, primarily flavonoids. However, we also hint at the presence of peptide and carbohydrate derivatives. The leaf extracts demonstrated the most promising metrics across all assays, exhibiting strong antioxidant and enzyme inhibitory effects as well as high levels of phenolic compounds, flavonoids, and tannins. Fingerprint analysis suggested potential peptide and carbohydrate metabolites as pancreatic lipase and α-glucosidase inhibitors. Overall, our study provides evidence on specific metabolites in Phoradendron brachystachyum that could be responsible for the therapeutic effects noted in obese and type 2 diabetes subjects.
1
1 October 2025 in Journal of the Mexican Chemical Society
A transcriptomic approach was employed to describe a set of putatively protein-coding sequences involved in the biosynthesis of berberine and sanguinarine, the two major benzylisoquinoline alkaloids (BIA) from Argemone mexicana (L.; Papaveraceae). A robust de novo assembled transcriptome was obtained from developing seedlings. Initial screening identified 514 unigenes, from eight different Pfam domains, such as Cyt-P450 dependent proteins, which are recurrently involved in BIA biosynthesis. Additional annotation by KEGG Orthology and Gene Ontology supported putative participation of the selected proteins in alkaloid biosynthesis. Moreover, in silico structure prediction of sanguinarine reductase (SanR), dihydrobenzophenantridine oxidase (DHBO) and tetrahydroprotoberberine oxidase (STOX), involved in the last reactions of sanguinarine and berberine biosynthesis, fitted to those of previously characterized proteins from related species, and thus, further supporting proper annotation. Hence, the pipeline analysis presented can provide a comprehensive description of the biosynthetic potential of this plant through functionality associated to its transcripts. Resumen. Un acercamiento transcriptómico se empleó para predecir un conjunto de secuencias condificantes para proteínas presuntamente involucradas en la biosíntesis de dos de los principales alcaloides bencilisoquinlínicos (ABI) en Argemone mexicana (L.; Papaveraceae). Un transcriptoma robusto, se obtuvo de plántulas en desarrollo. Un cribaje inicial identificó 514 unigenes de ocho dominios Pfam diferentes, incluyendo proteínas dependientes del CitP450, que participan en muchas reacciones en la biosíntesis de ABI. Anotaciones adicionales siguiendo la ortología KEGG y Gene Ontology sugirió la participación de un grupo de proteínas en la biosíntesis de alcaloides. Más aún, el modelaje estructural in silico de la sanguinarina reductasa (SanR), dihidrobenzophenantridina oxidasa (DHBO) y tetrahidroprotoberberine oxidase (STOX), responsables de las últimas reacciones de la síntesis de sanguinarina y berberina encajaron los previamente descritos para estas enzimas en otras especies relacionadas, confirmando la asignación recibida en la anotación. De este modo, el análisis bioinformático realizado puede ser útil para la descripción detallada del potencial biosintético de esta planta a través de la caracterización funcional de los candidatos seleccionados.